Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kenneth Carl Anderson Insider Profile
4 Followers
Kenneth Carl Anderson, Director at C4 Therapeutics, holds 320.42K shares in C4 Therapeutics (Ticker: CCCC).
Kenneth Carl Anderson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kenneth Carl Anderson's holdings
Insider Roles
Director
Roles that Kenneth Carl Anderson holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kenneth Carl Anderson
Kenneth Carl Anderson's Trading History
List of latest transactions for each holding click on a transaction to see Kenneth Carl Anderson's performance on stock
You May Also Like
Kenneth Carl Anderson insider profile FAQ
What is the percentage of profitable transactions made by Kenneth Carl Anderson?
The percentage of profitable transactions made by Kenneth Carl Anderson is ―.
What is the average return per transaction made by Kenneth Carl Anderson?
The average return per transaction made by Kenneth Carl Anderson is ―.
What stocks does Kenneth Carl Anderson hold?
Kenneth Carl Anderson holds: CCCC stocks.
What was Kenneth Carl Anderson’s latest transaction?
Kenneth Carl Anderson latest transaction was an Uninformative Buy of $11.25K.
What was Kenneth Carl Anderson's most profitable transaction?
Kenneth Carl Anderson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kenneth Carl Anderson's role in C4 Therapeutics?
Kenneth Carl Anderson's role in C4 Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.